31
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Delirium in critical illness: clinical manifestations, outcomes, and management

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Delirium is the most common manifestation of brain dysfunction in critically ill patients. In the intensive care unit (ICU), duration of delirium is independently predictive of excess death, length of stay, cost of care, and acquired dementia. There are numerous neurotransmitter/functional and/or injury-causing hypotheses rather than a unifying mechanism for delirium. Without using a validated delirium instrument, delirium can be misdiagnosed (under, but also overdiagnosed and trivialized), supporting the recommendation to use a monitoring instrument routinely. The best-validated ICU bedside instruments are CAM-ICU and ICDSC, both of which also detect subsyndromal delirium. Both tools have some inherent limitations in the neurologically injured patients, yet still provide valuable information about delirium once the sequelae of the primary injury settle into a new post-injury baseline. Now it is known that antipsychotics and other psychoactive medications do not reliably improve brain function in critically ill delirious patients. ICU teams should systematically screen for predisposing and precipitating factors. These include exacerbations of cardiac/respiratory failure or sepsis, metabolic disturbances (hypoglycemia, dysnatremia, uremia and ammonemia) receipt of psychoactive medications, and sensory deprivation through prolonged immobilization, uncorrected vision and hearing deficits, poor sleep hygiene, and isolation from loved ones so common during COVID-19 pandemic. The ABCDEF (A2F) bundle is a means to facilitate implementation of the 2018 Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS) Guidelines. In over 25,000 patients across nearly 100 institutions, the A2F bundle has been shown in a dose–response fashion (i.e., greater bundle compliance) to yield improved survival, length of stay, coma and delirium duration, cost, and less ICU bounce-backs and discharge to nursing homes.

          Related collections

          Most cited references97

          • Record: found
          • Abstract: not found
          • Book: not found

          Diagnostic and Statistical Manual of Mental Disorders

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

            To update and expand the 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the ICU.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Long-term cognitive impairment after critical illness.

              Survivors of critical illness often have a prolonged and disabling form of cognitive impairment that remains inadequately characterized. We enrolled adults with respiratory failure or shock in the medical or surgical intensive care unit (ICU), evaluated them for in-hospital delirium, and assessed global cognition and executive function 3 and 12 months after discharge with the use of the Repeatable Battery for the Assessment of Neuropsychological Status (population age-adjusted mean [±SD] score, 100±15, with lower values indicating worse global cognition) and the Trail Making Test, Part B (population age-, sex-, and education-adjusted mean score, 50±10, with lower scores indicating worse executive function). Associations of the duration of delirium and the use of sedative or analgesic agents with the outcomes were assessed with the use of linear regression, with adjustment for potential confounders. Of the 821 patients enrolled, 6% had cognitive impairment at baseline, and delirium developed in 74% during the hospital stay. At 3 months, 40% of the patients had global cognition scores that were 1.5 SD below the population means (similar to scores for patients with moderate traumatic brain injury), and 26% had scores 2 SD below the population means (similar to scores for patients with mild Alzheimer's disease). Deficits occurred in both older and younger patients and persisted, with 34% and 24% of all patients with assessments at 12 months that were similar to scores for patients with moderate traumatic brain injury and scores for patients with mild Alzheimer's disease, respectively. A longer duration of delirium was independently associated with worse global cognition at 3 and 12 months (P=0.001 and P=0.04, respectively) and worse executive function at 3 and 12 months (P=0.004 and P=0.007, respectively). Use of sedative or analgesic medications was not consistently associated with cognitive impairment at 3 and 12 months. Patients in medical and surgical ICUs are at high risk for long-term cognitive impairment. A longer duration of delirium in the hospital was associated with worse global cognition and executive function scores at 3 and 12 months. (Funded by the National Institutes of Health and others; BRAIN-ICU ClinicalTrials.gov number, NCT00392795.).
                Bookmark

                Author and article information

                Contributors
                joanna.stollings@vumc.org
                Journal
                Intensive Care Med
                Intensive Care Med
                Intensive Care Medicine
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0342-4642
                1432-1238
                16 August 2021
                : 1-15
                Affiliations
                [1 ]GRID grid.412807.8, ISNI 0000 0004 1936 9916, Critical Illness Brain Dysfunction Survivorship Center, , Nashville, Vanderbilt University Medical Center, ; 1211 Medical Center Drive, B-131 VUH, Nashville, TN 37232-7610 USA
                [2 ]GRID grid.412807.8, ISNI 0000 0004 1936 9916, Department of Pharmaceutical Services, , Vanderbilt University Medical Center, ; Nashville, TN USA
                [3 ]GRID grid.107950.a, ISNI 0000 0001 1411 4349, Department Anesthesiology, Intensive Therapy and Acute Intoxications, , Pomeranian Medical University, ; Szczecin, Poland
                [4 ]GRID grid.121334.6, ISNI 0000 0001 2097 0141, Department of Anaesthesia and Critical Care Medicine, Saint Eloi Hospital, Montpellier University Hospital Center, and PhyMedExp, , University of Montpellier, INSERM, CNRS, ; Montpellier, France
                [5 ]GRID grid.412807.8, ISNI 0000 0004 1936 9916, Division of Pulmonary and Critical Care Medicine, Department of Medicine, , Vanderbilt University Medical Center, ; Nashville, TN USA
                [6 ]GRID grid.412807.8, ISNI 0000 0004 1936 9916, Division of Anesthesiology Critical Care Medicine, Department of Anesthesiology, , Vanderbilt University Medical Center, ; Nashville, TN USA
                [7 ]GRID grid.412807.8, ISNI 0000 0004 1936 9916, Center for Health Services Research, , Vanderbilt University Medical Center, ; Nashville, TN USA
                [8 ]GRID grid.413806.8, Geriatric Research, Education and Clinical Center Service, Department of Veterans Affairs Medical Center, , Tennessee Valley Health Care System, ; Nashville, TN USA
                Author information
                http://orcid.org/0000-0001-6792-1646
                Article
                6503
                10.1007/s00134-021-06503-1
                8366492
                34401939
                f67af2ac-2e42-4317-a61a-0ea4f684f76f
                © Springer-Verlag GmbH Germany, part of Springer Nature 2021

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 3 January 2021
                : 29 July 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000049, National Institute on Aging;
                Award ID: R01-AG027472
                Award ID: R01-AG035117
                Award ID: R01-AG058639-02
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000050, National Heart, Lung, and Blood Institute;
                Award ID: R01 HL111111
                Award Recipient :
                Categories
                Narrative Review

                Emergency medicine & Trauma
                delirium,antipsychotics,icu liberation,cognitive impairment,critical care

                Comments

                Comment on this article